Comorbid conditions reported in patients with COPD recruited into a global clinical trial (UPLIFT) Source: Annual Congress 2005 - Systemic effects of COPD Year: 2005
Top-10 comorbidities of symptomatic patients with moderate COPD in the clinical setting of the CRYSTAL study Source: International Congress 2016 – Features and impact of comorbidities in COPD Year: 2016
Water-based exercise in people with COPD and physical co-morbid conditions: A randomised controlled trial Source: Annual Congress 2010 - Talent competition in rehabilitation and chronic care: best abstract grants 2010 Year: 2010
Treatment eligibility of mepolizumab-treated severe asthma patients in clinical practice Source: International Congress 2019 – Real-world experience of monoclonal antibodies in asthma Year: 2019
Exacerbation action plans for patients with COPD and comorbidities: a randomised controlled trial Source: Eur Respir J, 54 (5) 1802134; 10.1183/13993003.02134-2018 Year: 2019
Evidence generation for the clinical impact of myCOPD in patients with mild, moderate and newly diagnosed COPD: a randomised controlled trial Source: ERJ Open Res, 6 (4) 00460-2020; 10.1183/23120541.00460-2020 Year: 2020
Co-morbid asthma in COPD patients in the UK Source: Annual Congress 2010 - Comorbidity in obstructive airway disease Year: 2010
COPD treatment from pathophysiology to clinical trials Source: ERS Live 2007 Year: 2007
Clinical characteristics and outcomes in hospitalized COVID-19 patients with COPD Source: Virtual Congress 2021 – COVID-19 and obstructive diseases: risk factors, management and long-term effects Year: 2021
Differences in patient characteristics and associations with comorbid load in Dutch and Australian COPD patients Source: International Congress 2016 – Latest insights into chronic care Year: 2016
Clinical characteristics of patients with frequent COPD exacerbations in a Swiss multicenter COPD cohort study (TOPDOCS) Source: International Congress 2016 – Targeting care, pulmonary rehabilitation, management, and self-management of COPD exacerbations in primary care Year: 2016
Need for generalized criteria in evaluating the impact of new drugs in clinical trials involving patients suffering from COPD Source: Annual Congress 2006 - Outcomes for COPD pharmacological trials: from lung function to biomarkers Year: 2006
Clinical and inflammatory characteristics of patients with COPD in primary care: an observational study Source: International Congress 2017 – Markers of COPD progression Year: 2017
A systematic evaluation of the diagnostic criteria for COPD and exacerbations used in randomised controlled trials on the management of COPD exacerbations Source: ERJ Open Res, 5 (4) 00136-2019; 10.1183/23120541.00136-2019 Year: 2019
Analysis of comorbid conditions in 1210 IPF patients from the EMPIRE registry Source: International Congress 2017 – Idiopathic pulmonary fibrosis (IPF): clinical problems Year: 2017
A randomised clinical trial to assess the effect of active muscle stimulation on hospitalised patients with COPD exacerbations Source: Annual Congress 2012 - The best posters on physical inactivity, muscle dysfunction and exercise intolerance Year: 2012
Baseline characteristics of COPD patients with frequent COPD exacerbations in tiotropium trials Source: Eur Respir J 2006; 28: Suppl. 50, 175s Year: 2006
Cognitive impairment and clinical characteristics in patients with COPD Source: International Congress 2016 – Latest insights into the management of chronic respiratory diseases Year: 2016
The utility of tiotropium among patients with chronic obstructive pulmonary disease (COPD): An updated meta-analysis of randomized controlled trials Source: Annual Congress 2013 –Quality of diagnosis and assessment in primary care Year: 2013
A clinical and outcomes assessment of the management of acute episodes of chronic bronchitis (AECB) : the MOSAIC study - baseline characteristics of screened patients Source: Eur Respir J 2002; 20: Suppl. 38, 544s Year: 2002